Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1624 1656
This examiner grants 100% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18449807 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND IPATASERTIB | Non-Final OA | Genentech, Inc. |
| 18284531 | CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE | Non-Final OA | Bristol-Myers Squibb Company |
| 18339773 | USES OF ORAI1-SPECIFIC CALCIUM CHANNELS IN TREATMENT OF ORAL CANCER | Non-Final OA | New York University |
| 18335687 | DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF | Non-Final OA | Japan Tobacco Inc. |
| 18512088 | METHODS FOR TREATING POXVIRUS INFECTIONS | Non-Final OA | Gilead Sciences, Inc. |
| 18337253 | LYSERGIC ACID DERIVATIVES WITH MODIFIED LSD-LIKE ACTION | Non-Final OA | Mind Medicine, Inc. |
| 18284523 | HEAD LICE TREATMENT | Non-Final OA | Nitoff Limited |
| 18284515 | PROCESS FOR THE PREPARATION OF CYCLEN | Non-Final OA | SERICHIM SRL |
| 18228086 | Processes for the Preparation of Fenfluramine | Non-Final OA | Apotex Inc. |
| 18263434 | ORAL PREPARATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Non-Final OA | ZHUHAI UNITED LABORATORIES CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy